For instance, scientists have modified Lactococcus lactis to produce both anti-PD-L1 nanobodies and anti-CTLA-4 antibodies, resulting in a strong synergistic effect that significantly enhanced tumor suppression in breast cancer animal models 165. The gene discussed is CTLA4; the disease is neoplasm.